Definitions
from The American Heritage® Dictionary of the English Language, 5th Edition.
- noun A chimeric monoclonal antibody used to treat certain types of non-Hodgkin's lymphoma and refractory rheumatoid arthritis.
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A
chimeric monoclonal antibody against theprotein CD20, used in the treatment oflymphomas ,leukemias , and someautoimmune disorders.
Etymologies
from The American Heritage® Dictionary of the English Language, 4th Edition
from Wiktionary, Creative Commons Attribution/Share-Alike License
Support
Help support Wordnik (and make this page ad-free) by adopting the word rituximab.
Examples
-
Rituxan, known generically as rituximab, is made by Genentech, a unit of Roche Holding AG and Biogen Idec Inc.
Boing Boing 2009
-
Newer therapies are emerging as more promising, perhaps the most impressive of which is Rituxan, also known as rituximab, now being used to treat those with multiple sclerosis and other autoimmune diseases.
The Autoimmune Epidemic Donna Jackson Nakazawa 2008
-
Newer therapies are emerging as more promising, perhaps the most impressive of which is Rituxan, also known as rituximab, now being used to treat those with multiple sclerosis and other autoimmune diseases.
The Autoimmune Epidemic Donna Jackson Nakazawa 2008
-
MabThera, sold in the U.S. by Genentech Inc. under the brand name Rituxan and generically known as rituximab, is Roche's best-selling drug.
-
In March this year, Nice issued new guidance recommending the use of a drug called rituximab (MabThera), but saying adalimumab (Humira), etanercept (Enbrel) and infliximab (Remicade) could only be used in the context of research, even for those patients who had failed on one anti-TNF.
icLiverpool 2010
-
TLR4 was also found to be associated with the response to rituximab, which is used in the treatment of many lymphomas, leukemias, and some autoimmune disorders
PLoS ONE Alerts: New Articles Gang Wu et al. 2010
-
According to Xconomy, Theraclone formed an alliance last year with the Tokyo-based company, which markets a blockbuster antibody drug for cancer and rheumatoid arthritis called rituximab (Rituxan) in Japan.
PhysOrg.com - latest science and technology news stories 2010
-
According to Xconomy, Theraclone formed an alliance last year with the Tokyo-based company, which markets a blockbuster antibody drug for cancer and rheumatoid arthritis called rituximab (Rituxan) in Japan.
PhysOrg.com - latest science and technology news stories 2010
-
According to Xconomy, Theraclone formed an alliance last year with the Tokyo-based company, which markets a blockbuster antibody drug for cancer and rheumatoid arthritis called rituximab (Rituxan) in Japan.
PhysOrg.com - latest science and technology news stories 2010
-
Under current guidelines, patients qualify for rituximab, which is marketed as MabThera, only on failing to respond to an anti-TNF.
Food &Health Skeptic 2009
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.